Tadagra 40mg Strong

What is Tadagra Strong 40mg ??



The presented preparation called tadagra strong is in the form of small yellow, oval tablets with the number 40 engraved on one side of the tablet which indicates the amount of active ingredient tadalafil 40mg.

What is Tadagra Strong 40mg used for?

Tadalafil is used to treat disorders called erections (also called impotence).

 In adult men, consisting of the inability to obtain or maintain an erection of the penis (erection) sufficiently to achieve satisfactory sexual intercourse. For Tadalafil to be effective, sexual stimulation is required. How to use Tadalafil? The recommended dose of Tadalafil is 40mg, taken with or without food, but the absorption time is significantly longer, it is used on an empty stomach at least 30 minutes before sexual activity. The maximum recommended frequency of use is one tablet per day. Patients with hepatic impairment or severe renal impairment should take a dose of no more than 10 mg per 24 hours. Continuous daily use of Tadalafil is strongly discouraged, because its effect usually lasts longer than one day, i.e. up to 36 hours, and the safety of long-term use of the preparation after prolonged daily dosing is not sufficiently known.


How does Tadagra Strong 40mg work?

The active substance in Tadalafil belongs to a group of medicines called 'phosphodiesterase 5 (PDE5) inhibitors'. Tadalafil inhibits the phosphodiesterase enzyme, which normally breaks down a substance known as cyclic GMP (cGMP). During normal sexual stimulation, cGMP is produced in the penis, where it causes the smooth muscle of the corpus cavernosa (corpora cavernosa) to relax, allowing more blood to enter the corpus cavernosum, which causes an erection. By inhibiting the breakdown of cGMP, Tadalafil restores erection. However, sexual stimulation is still needed.


How has the drug component been studied, Tadalafil ??

Tadalafil has been studied in six main studies involving 1,328 patients, which were compared with placebo (a dummy treatment). One study only included men with © EMEA 2006 2/2 diabetes. The determinant of effectiveness was the ability to get and maintain an erection. The information was recorded in two questionnaires completed at home.

What benefits of the preparation have been observed in studies ??

Tadalafil was significantly more effective than placebo in all studies. In one of the questionnaires, where the maximum number of points was 30, patients who obtained a result close to 15 after receiving Tadalafil 40mg obtained a score of 22.6 or 25, respectively. Overall, in the general population studies, 80% of patients reported an improvement erection after taking Tadalafil compared with 34% of patients using placebo.

What is the risk associated with Tadagra Strong 40mg?

The most common side effects (in more than 1 patient in 10) are headache and indigestion. For the full list of all side effects reported with Tadalafil, see the Package Leaflet. Tadalafil should not be used by people who are hypersensitive (allergic) to tadalafil or any of the other ingredients of the preparation and for whom sexual activity is not indicated (e.g. men with heart disease). Scifilnie should also be taken by patients who have suffered a loss of vision due to impaired blood flow to the nerve in the eye (NAION, or ischemic anterior optic neuropathy). Taking Tadalafil with nitrates (medicines to treat angina) is contraindicated. Physicians should consider the potential risk of sexual dysfunction in men with cardiovascular disease. Tadalafil has not been studied in patients who have had a heart attack in the last 3 months or who have had a stroke or have had a blood or heart pressure disorder (irregular heartbeat) in the last 6 months. For the full list of restrictions, see the package leaflet.

Why has Tadalafil been approved?

The Committee for Medicinal Products for Human Use (CHMP) decided that the benefits of Tadalafil outweigh its risks for the treatment of men with erectile dysfunction. The Committee recommended that Tadalafil be given marketing authorization. Other information about Tadalafil; On November 12, 2002, the European Commission granted Lilly ICOS Limited a marketing authorization for Tadalafil that is valid throughout the European Union.